Although BO has been confirmed to be a p-glycoprotein inhibitor and increases distributions of many drugs in the brain (Yu et al., 2013a; Yu et al., 2013b), its brain-targeting effect is meaningless when the BBB structure is destructed during cerebral ischemia. Here, ABCB1 is linked to brain ischemia.